Skip to main content

Advertisement

SpringerLink
Log in

Age-Related Changes in the Metabolic Activity and Distribution of the Red Marrow as Demonstrated by 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Objectives

The objective of the study was to determine age-related changes occurring in red marrow with regard to its distribution and the degree of its metabolic activity by whole-body 2-deoxy-2-[F-18]fluoro-d-glucose (FDG)-positron emission tomography (PET).

Methods

This retrospective study included 112 patients (56 male, 56 female, mean age 40 years, range 2–85) who underwent whole-body FDG-PET scans for assessment of disorders that were determined not to affect red marrow activity. These patients were categorized into the following groups with equal gender distribution: 0–15 years (12 individuals), 16–25 years (20), 26–35 years (10), 36–45 years (20), 46–55 years (14), 56–65 years (16), 66–75 years (14), and 76–85 years (6). Whole-body FDG-PET images were performed at 60 min after the intravenous administration of 0.14 mCi/kg of FDG. By employing a dedicated whole-body PET scanner. Maximal standardized uptake value (SUVmax) was calculated from three consecutive transverse sections of the upper thirds of the humeri and femora, manubrium of the sternum, 12th thoracic and 5th lumbar vertebra and anterior superior iliac crests of the pelvis. All available results from other imaging examinations [magnetic resonance imaging (MRI), computed tomography (CT), and conventional radiolography], laboratory data, biopsies, and the clinical course of these subjects were reviewed to make certain that the bone marrow sites examined were free of any known pathologies.

Results

SUVmax in the extremities showed significant decline with aging (correlation coefficient of −0.60 to −0.67, p < 0.01). In contrast, a weak correlation was noted in the axial skeletal activity with advancing age (correlation coefficient of −0.28 to −0.48, p < 0.05).

Conclusions

These data suggest that FDG metabolic activity of the red marrow in the extremities decline significantly with normal aging, while that of the axial skeleton show minimal decrease related to this biologic phenomenon. These findings are of value in assessing the effects of hematological and other disorders in the distribution and the metabolic activity of this important tissue and testing therapeutic interventions that are employed for treating such maladies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. Zhao P, Liu W, Cui Y (2006) Rapid immune reconstitution and dendritic cell engraftment post-bone marrow transplantation with heterogeneous progenitors and GM-CSF treatment. Exp Hematol 34:951–964, Jul

    Article  PubMed  CAS  Google Scholar 

  2. Zhang Y, Adachi Y, Iwasaki M, Minamino K, Suzuki Y, Nakano K, Koike Y, Mukaide H, Shigematsu A, Kiriyama N, Li C, Ikehara S (2006) G-CSF and/or M-CSF accelerate differentiation of bone marrow cells into endothelial progenitor cells in vitro. Oncol Rep 15:1523–1527, Jun

    PubMed  CAS  Google Scholar 

  3. Gazitt Y, Akay C, Thomas C 3rd (2006) No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-Hodgkin’s lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF. Stem Cells Dev 15:269–277, Apr

    Article  PubMed  CAS  Google Scholar 

  4. Johnston KL, Farnen JP, Manske BR, Go RS (2005) Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors. Haematologica 90(12 Suppl), Dec

  5. Blodgett TM, Ames JT, Torok FS, McCook BM, Meltzer CC (2004) Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med 29:161–163, Mar

    Article  PubMed  Google Scholar 

  6. Brynes RK, McKenna RW, Sundberg RD (1978) Bone marrow aspiration and trephine biopsy: an approach to a thorough study. Am J Clin Pathol 70:753–759, Nov

    PubMed  CAS  Google Scholar 

  7. Ellis LD, Jensen JN, Westerman MF (1964) Needle biopsy of bone and marrow: an experience with 1,445 biopsies. Arch Intern Med 114:213–214

    PubMed  CAS  Google Scholar 

  8. James LP, Stass SA, Schumacher HR (1980) Value of imprint preparations of bone marrow biopsies in hematologic diagnosis. Cancer 46:173–177, Jul 1

    Article  PubMed  CAS  Google Scholar 

  9. Jamshidi K, Swaim WR (1971) Bone marrow biopsy with unaltered architecture: a new biopsy device. J Lab Clin Med 77:335–342, Feb

    PubMed  CAS  Google Scholar 

  10. Knowles S, Hoffbrand AV (1980) Bone-marrow aspiration and trephine biopsy (1). Br Med J 281:204–205, Jul 19

    PubMed  CAS  Google Scholar 

  11. Steiner RM, Mitchell DG, Rao VM, et al. (1993) Magnetic resonance imaging of diffuse bone marrow disease. Radiol Clin North Am 31:383–409

    PubMed  CAS  Google Scholar 

  12. Federico M, Magin RL, Swartz HM, et al. (1989) Detection of bone marrow involvement in patients with cancer. Tumori 75:90–96

    PubMed  CAS  Google Scholar 

  13. Alavi A, Kung JW, Zhuang H (2004) Implications of PET based molecular imaging on the current and future practice of medicine. Semin Nucl Med 34:56–69

    Article  PubMed  Google Scholar 

  14. Belhocine T, Spaepen K, Dusart M, Castaigne C, Muylle K, Bourgeois P, Bourgeois D, Dierickx L, Flamen P (2006) 18FDG-PET in oncology: the best and the worst. Int J Oncol 28:1249–1261, May

    PubMed  Google Scholar 

  15. Kumar R, Nadig MR, Chauhan A (2005) Positron emission tomography: clinical applications in oncology. Part 1. Expert Rev Anticancer Ther (6):1079–1094, Dec 5

    Article  Google Scholar 

  16. Wechalekar K, Sharma B, Cook G (2005) PET/CT in oncology—a major advance. Clin Radiol 60:1143–1155, Nov

    Article  PubMed  CAS  Google Scholar 

  17. Kazama T, Swanston N, Podoloff DA, Macapinlac HA (2005) Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 32:1406–1411, Dec. Epub 2005 Aug 31

    Article  PubMed  CAS  Google Scholar 

  18. Meyer MA, Nathan CA (2000) Reduced F-18 fluorodeoxyglucose uptake within marrow after external beam radiation. Clin Nucl Med 25:279–280, Apr

    Article  PubMed  CAS  Google Scholar 

  19. Kricun ME (1985) Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol 14:10–19

    Article  PubMed  CAS  Google Scholar 

  20. Hashimoto M (1962) Pathology of bone marrow. Acta Haematol 27:193–216

    Article  PubMed  CAS  Google Scholar 

  21. Dunnhill MS, Anderson JH, Whitehead R (1967) Quantitative histological studies on age changes in bone. J Pathol Bacteriol 94:275–291

    Article  Google Scholar 

  22. Vogler JB 3rd, Murphy WA (1988) Bone marrow imaging. Radiology 168:679–693

    PubMed  Google Scholar 

  23. Desai AG, Thakur ML (1985) Radiopharmaceuticals for spleen and bone marrow studies. Semin Nucl Med 15:229–238

    Article  PubMed  CAS  Google Scholar 

  24. Datz FL, Taylor A Jr (1985) The clinical use of radionuclide bone marrow imaging. Semin Nucl Med 15:239–259

    Article  PubMed  CAS  Google Scholar 

  25. Engstedt L, Franzen S, Jonsson L, et al. (1958) In vivo localization of colloidal Au198 intravenously injected in polycythemia vera: a preliminary report. Acta Radiol 49:66–71

    Article  PubMed  CAS  Google Scholar 

  26. Silberstein B (1998) Nuclear hematology: the erythron. In: Nucl Med Annual 163–174

  27. Kim C, Reske S.N, Abass Alavi (1996) Bone marrow scintigraphy. In: Henkin R., et al. (eds) Nuclear medicine. By Mosby-Year book, pp 1223–124

  28. Herbert CJ, et al (eds). (1996) Nuclear medicine: diagnosis and therapy. New York, NY: By Thieme medical Publishers, Inc., pp 780–784

  29. Van Dyke D, Price D, Shkurkin C, et al. (1967) Differences in distribution of erythropoietic and reticuloendothelial marrow in hematologic disease. Blood 30:364–374

    PubMed  Google Scholar 

  30. Hotze A, Low A, Mahlstedt J, et al. (1984) Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases. Rofo 140:717–723

    PubMed  CAS  Google Scholar 

  31. Blend MJ, Pavel DG (1986) Bone marrow imaging: a comparison study using a 99m Tc-sulphur colloid versus a new 99m Tc microaggregated albumin. Nucl Med Commun 7:787–789

    Article  PubMed  CAS  Google Scholar 

  32. Beamish MR, Brown EB (1974) The metabolism of transferrin-bound 111In and 59Fe in the rat. Blood 43:693–701

    PubMed  CAS  Google Scholar 

  33. Bourgeois P, Demonceau G, Stegen M, et al. (1991) 99Tcm-HMPAO-labelled leucocytes for bone marrow scintigraphy and evaluation of skeletal lesions: comparison with 99Tcm-HSA colloid results. Nucl Med Commun 12:621–627

    Article  PubMed  CAS  Google Scholar 

  34. Duncker CM, Carrio I, Berna L, et al. (1990) Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 31:1450–1455

    PubMed  CAS  Google Scholar 

  35. Munz DL, Sandrock D, Rilinger N (1990) Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow. Lancet 336:258–259

    Article  PubMed  CAS  Google Scholar 

  36. Reske SN, Buell U (1990) Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution: technical note. Eur J Nucl Med 17:38–41

    Article  PubMed  CAS  Google Scholar 

  37. Reske SN, Karstens JH, Gloeckner W, et al. (1989) Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1:299–301

    Article  PubMed  CAS  Google Scholar 

  38. Alavi A, Lakhani P, Mavi A, et al. (2004) PET: a revolution in medical imaging. Radiol Clin North Am 42:983–1001

    Article  PubMed  Google Scholar 

  39. Cheran SK, Herndon JE 2nd, Patz EF Jr (2004) Comparison of whole-body FDG to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44:317–325

    Article  PubMed  Google Scholar 

  40. Durski JM, Srinivas S, Segall G (2000) Comparison of GDF-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer. Clin Positron Imaging 3:97–105

    Article  PubMed  Google Scholar 

  41. El-Haddad G, Zhuang H, Gupta N, et al. (2004) Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med 34:313–329

    Article  PubMed  Google Scholar 

  42. Shreve PD, Anzai Y, Wahl RL (1999) Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 19:61–77

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, Hospital of University of Pennsylvania, Philadelphia, PA, USA

    Chengzhong Fan, Miguel Hernandez-Pampaloni, Mohamed Houseni, Wichana Chamroonrat, Sandip Basu, Rakesh Kumar, Simin Dadparvar & Abass Alavi

  2. Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA

    Drew A. Torigian

  3. Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China

    Chengzhong Fan

Authors
  1. Chengzhong Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miguel Hernandez-Pampaloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohamed Houseni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wichana Chamroonrat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sandip Basu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rakesh Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Simin Dadparvar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Drew A. Torigian
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Abass Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abass Alavi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fan, C., Hernandez-Pampaloni, M., Houseni, M. et al. Age-Related Changes in the Metabolic Activity and Distribution of the Red Marrow as Demonstrated by 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography. Mol Imaging Biol 9, 300–307 (2007). https://doi.org/10.1007/s11307-007-0100-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-007-0100-9

Key words

Search

Navigation